Literature DB >> 29725446

Overexpression of CD155 relates to metastasis and invasion in osteosarcoma.

Baobiao Zhuo1,2, Yuan Li2, Feng Gu3, Zhengwei Li2, Qingzeng Sun2, Yingchun Shi2, Yang Shen2, Fengfei Zhang2, Rong Wang4, Xiaodong Wang1.   

Abstract

The rapid development of metastatic lesions remains the leading cause of mortality for patients with osteosarcoma. CD155 serves a key role in cancer cell migration, invasion and metastasis. However, the function and mechanism of CD155 has not been explored in osteosarcoma metastasis. In the present study, we found that CD155 was significantly upregulated in lung metastatic tissue and the highly metastatic cell line K7M2-WT (K7M2) of osteosarcoma. Overexpression of CD155 in K7M2 cells enhanced lung metastasis, while inhibition of CD155 by an anti-CD155 monoclonal antibody reduced metastasis. Blocking of CD155 also decreased migration and invasion of K7M2 cells in vitro. A western blot analysis revealed that blocking of CD155 inhibits metastasis by downregulating focal adhesion kinase (FAK) and phosphorylated FAK (pFAK) in osteosarcoma. The results revealed that CD155 serves a crucial role in the metastasis of osteosarcoma by regulating FAK and may provide a novel molecular target for therapeutic intervention in metastatic osteosarcoma.

Entities:  

Keywords:  CD155; invasion; metastasis; migration; osteosarcoma

Year:  2018        PMID: 29725446      PMCID: PMC5920504          DOI: 10.3892/ol.2018.8228

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

Review 1.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

2.  Focal adhesion kinase is involved in the migration of human osteosarcoma cells.

Authors:  Sitan Feng; Xin Shi; K E Ren; Sujia Wu; Xiaoliang Sun
Journal:  Oncol Lett       Date:  2015-04-21       Impact factor: 2.967

3.  Clinical significance of CD155 expression in human pancreatic cancer.

Authors:  Satoshi Nishiwada; Masayuki Sho; Satoshi Yasuda; Keiji Shimada; Ichiro Yamato; Takahiro Akahori; Shoichi Kinoshita; Minako Nagai; Noboru Konishi; Yoshiyuki Nakajima
Journal:  Anticancer Res       Date:  2015-04       Impact factor: 2.480

4.  Oncolytic virotherapy for human bone and soft tissue sarcomas using live attenuated poliovirus.

Authors:  Satoru Atsumi; Akihiko Matsumine; Hidemi Toyoda; Rui Niimi; Takahiro Iino; Tomoki Nakamura; Takao Matsubara; Kunihiro Asanuma; Yoshihiro Komada; Atsumasa Uchida; Akihiro Sudo
Journal:  Int J Oncol       Date:  2012-06-12       Impact factor: 5.650

Review 5.  Systems microscopy approaches to understand cancer cell migration and metastasis.

Authors:  Sylvia E Le Dévédec; Kuan Yan; Hans de Bont; Veerander Ghotra; Hoa Truong; Erik H Danen; Fons Verbeek; Bob van de Water
Journal:  Cell Mol Life Sci       Date:  2010-06-18       Impact factor: 9.261

Review 6.  Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters.

Authors:  Frank Entschladen; Theodore L Drell; Kerstin Lang; Jan Joseph; Kurt S Zaenker
Journal:  Lancet Oncol       Date:  2004-04       Impact factor: 41.316

7.  Treatment of intracerebral neoplasia and neoplastic meningitis with regional delivery of oncolytic recombinant poliovirus.

Authors:  Hidenobu Ochiai; Stephanie A Moore; Gary E Archer; Tatsunori Okamura; Tracy A Chewning; Jeffrey R Marks; John H Sampson; Matthias Gromeier
Journal:  Clin Cancer Res       Date:  2004-07-15       Impact factor: 12.531

Review 8.  Roles of cell adhesion molecules nectin and nectin-like molecule-5 in the regulation of cell movement and proliferation.

Authors:  H Ogita; W Ikeda; Y Takai
Journal:  J Microsc       Date:  2008-09       Impact factor: 1.758

9.  Prognostic significance of CD155 mRNA expression in soft tissue sarcomas.

Authors:  Satoru Atsumi; Akihiko Matsumine; Hidemi Toyoda; Rui Niimi; Takahiro Iino; Akihiro Sudo
Journal:  Oncol Lett       Date:  2013-04-02       Impact factor: 2.967

10.  FAK is a critical regulator of neuroblastoma liver metastasis.

Authors:  Sora Lee; Jingbo Qiao; Pritha Paul; Kathleen L O'Connor; Mark B Evers; Dai H Chung
Journal:  Oncotarget       Date:  2012-12
View more
  11 in total

1.  Diosgenin inhibits the epithelial-mesenchymal transition initiation in osteosarcoma cells via the p38MAPK signaling pathway.

Authors:  Huaming Huang; Chao Nie; Xiaokang Qin; Jie Zhou; Lei Zhang
Journal:  Oncol Lett       Date:  2019-08-23       Impact factor: 2.967

2.  CD155 expression impairs anti-PD1 therapy response in non-small cell lung cancer.

Authors:  Chang Jiang; Xiaodie Qu; Li Ma; Ling Yi; Xu Cheng; Xiang Gao; Jinghui Wang; Nanying Che; Hongtao Zhang; Shucai Zhang
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

3.  MALAT1 promotes proliferation, migration, and invasion of MG63 cells by upregulation of TGIF2 via negatively regulating miR-129.

Authors:  Kai Liu; Yingang Zhang; Liang Liu; Qiling Yuan
Journal:  Onco Targets Ther       Date:  2018-12-04       Impact factor: 4.147

4.  Down-regulation of PDGFRβ suppresses invasion and migration in osteosarcoma cells by influencing epithelial-mesenchymal transition.

Authors:  Sining Xing; Changdong Wang; Huying Tang; Jiaqi Guo; Xing Liu; Faping Yi; Geli Liu; Xiangmei Wu
Journal:  FEBS Open Bio       Date:  2020-08-03       Impact factor: 2.693

5.  High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.

Authors:  An-Li Jin; Yi-Hui Yang; Xi Su; Wen-Jing Yang; Te Liu; Wei Chen; Tong Li; Lin Ding; Hao Wang; Bei-Li Wang; Bai-Shen Pan; Jian Zhou; Jia Fan; Xin-Rong Yang; Wei Guo
Journal:  J Clin Lab Anal       Date:  2022-01-28       Impact factor: 2.352

6.  ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway.

Authors:  Yong Cui; Yong-Yong Dong
Journal:  Aging (Albany NY)       Date:  2022-09-19       Impact factor: 5.955

7.  Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study.

Authors:  Yu-Chen Li; Quan Zhou; Qing-Kun Song; Rui-Bin Wang; Shuzhen Lyu; Xiudong Guan; Yan-Jie Zhao; Jiang-Ping Wu
Journal:  J Immunol Res       Date:  2020-01-13       Impact factor: 4.818

Review 8.  Exosomes in Bone Sarcomas: Key Players in Metastasis.

Authors:  Mariona Chicón-Bosch; Oscar M Tirado
Journal:  Cells       Date:  2020-01-17       Impact factor: 6.600

9.  Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.

Authors:  Xiuman Zhou; Jiangfeng Du; Hongfei Wang; Chunxia Chen; Ling Jiao; Xiangrui Cheng; Xiaowen Zhou; Shaomeng Chen; Shanshan Gou; Wenshan Zhao; Wenjie Zhai; Junhui Chen; Yanfeng Gao
Journal:  Cell Commun Signal       Date:  2020-09-07       Impact factor: 5.712

10.  A Poliovirus Receptor (CD155)-Related Risk Signature Predicts the Prognosis of Bladder Cancer.

Authors:  Cong Luo; Wenrui Ye; Jiao Hu; Belaydi Othmane; Huihuang Li; Jinbo Chen; Xiongbing Zu
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.